chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chest discomfort, Dizziness, Feeling jittery
Clinical narrative: Immediately rapid pulse; feeling of dizziness; joint pain; heaviness in chest/pressure in face/sinuses/neck throat and chest area, feeling jittery; plus headache; weakness; pressure in face/sinuses/neck throat and chest area, feeling jittery; skin itching; pressure in face/sinuses/neck throat and chest area, feeling jittery; This is spontaneous report from a contactable consumer (patient) reported for herself. A 55-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6203, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 02Mar2021 at 18:45 pm (age at vaccination was 55 years) as dose 1, single for COVID-19 immunization. The patient's concomitant medications were not reported. The patient previous took MMR vaccine and had a strong allergic reaction as a child. The patient did not receive any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 02Mar2021 at 18:45 pm, the patient experienced immediately rapid pulse, feeling of dizziness, joint pain, heaviness in chest. Continued to next day, plus headache, weakness, pressure in face/sinuses/neck throat and chest area, feeling jittery, skin itching. No treatment was received for the adverse events. The patient underwent lab test which included heart rate: immediately rapid pulse on 02Mar2021. The case was reported as non-serious. The outcome of the events was not resolved.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Paranasal sinus discomfort, Pruritus
Clinical narrative: Immediately rapid pulse; feeling of dizziness; joint pain; heaviness in chest/pressure in face/sinuses/neck throat and chest area, feeling jittery; plus headache; weakness; pressure in face/sinuses/neck throat and chest area, feeling jittery; skin itching; pressure in face/sinuses/neck throat and chest area, feeling jittery; This is spontaneous report from a contactable consumer (patient) reported for herself. A 55-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6203, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 02Mar2021 at 18:45 pm (age at vaccination was 55 years) as dose 1, single for COVID-19 immunization. The patient's concomitant medications were not reported. The patient previous took MMR vaccine and had a strong allergic reaction as a child. The patient did not receive any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 02Mar2021 at 18:45 pm, the patient experienced immediately rapid pulse, feeling of dizziness, joint pain, heaviness in chest. Continued to next day, plus headache, weakness, pressure in face/sinuses/neck throat and chest area, feeling jittery, skin itching. No treatment was received for the adverse events. The patient underwent lab test which included heart rate: immediately rapid pulse on 02Mar2021. The case was reported as non-serious. The outcome of the events was not resolved.   No follow-up attempts are possible. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Malaise, Pain
Clinical narrative: Fever to 100.7; Headache; body aches; tiredness; sore arm; blurred vision; overall feeling unwell; This is a spontaneous report from a contactable consumer (patient). A 58-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 02Mar2021 at 01:30 (at the age of 58-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included dry sinuses and sinus irritation, COVID-19 and known allergies to Penicillin. The patient concomitant medications included Prednisone from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 12:00, the patient experienced fever to 100.7. headache, body aches, tiredness, sore arm, blurred vision, overall feeling unwell. The patient did not receive treatment for events. The outcome of the events was recovering.  No Follow-up attempts are possible. Information about lot/batch cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Vision blurred
Clinical narrative: Fever to 100.7; Headache; body aches; tiredness; sore arm; blurred vision; overall feeling unwell; This is a spontaneous report from a contactable consumer (patient). A 58-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 02Mar2021 at 01:30 (at the age of 58-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included dry sinuses and sinus irritation, COVID-19 and known allergies to Penicillin. The patient concomitant medications included Prednisone from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 12:00, the patient experienced fever to 100.7. headache, body aches, tiredness, sore arm, blurred vision, overall feeling unwell. The patient did not receive treatment for events. The outcome of the events was recovering.  No Follow-up attempts are possible. Information about lot/batch cannot be obtained.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: 101 Fever; chills; headache; body aches; fatigue; This is a spontaneous report received from a contactable consumer or other non hcp. A 75-years-old non-pregnant female patient received BNT162B2, (formulation: solution of injection), dose 2 via an unspecified route of administration, administered in Right Arm on 01Mar2021 14:30 (Batch/Lot Number: EN6205) as single dose for covid-19 immunisation. Medical history included, asthma from an unknown date and unknown if ongoing, depression from an unknown date and unknown if ongoing, hypothyroidism from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took avelox and experienced drug hypersensitivity, amoxicillin and experienced drug hypersensitivity, vicodin and experienced drug hypersensitivity.The patient previously received first dose BNT162B2 (formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08feb2021 02:30 (Batch/Lot number:EL9262) as single dose for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. the patient did not receive any other vaccine in four weeks.On 02Mar2021 07:00 AM, the patient experienced 101 fever, chills, headache, body aches and fatigue.The patient did not receive any treatment for the events. the clinical outcome for all the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 101 Fever; chills; headache; body aches; fatigue; This is a spontaneous report received from a contactable consumer or other non hcp. A 75-years-old non-pregnant female patient received BNT162B2, (formulation: solution of injection), dose 2 via an unspecified route of administration, administered in Right Arm on 01Mar2021 14:30 (Batch/Lot Number: EN6205) as single dose for covid-19 immunisation. Medical history included, asthma from an unknown date and unknown if ongoing, depression from an unknown date and unknown if ongoing, hypothyroidism from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took avelox and experienced drug hypersensitivity, amoxicillin and experienced drug hypersensitivity, vicodin and experienced drug hypersensitivity.The patient previously received first dose BNT162B2 (formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 08feb2021 02:30 (Batch/Lot number:EL9262) as single dose for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. the patient did not receive any other vaccine in four weeks.On 02Mar2021 07:00 AM, the patient experienced 101 fever, chills, headache, body aches and fatigue.The patient did not receive any treatment for the events. the clinical outcome for all the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19, UNK
Symptoms: Rash
Clinical narrative: rash breakout on both of calves; This is a spontaneous report from a non-contactable consumer. This patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (lot number: EN6202) at single dose for COVID-19 immunisation. The patient also received hydrocortisone injection via unspecified route of administration at unspecified dosage every six months for a sport injury. The patient's medical history included sport injury. The patient's concomitant medications were not reported. The patient had vaccine shot on Friday (unspecified date). The patient was also getting every six months hydrocortisone shots for like a sport injury because the patient work in a university. The patient had a rash breakout on both of calves and like it is a floaty rash. It is not like all in one place it is like around upper part where ankle is, in the middle of calve where muscle is and around the side of the calve. The patient wanted to know did medication/vaccine get into blood stream and caused this rash in skin and what's the deal. The patient stated would go to doctor and orthopedic surgeon. The action taken of COVID-19 vaccine was not applicable. The action taken of hydrocortisone was unknown. The outcome of the events was unknown.   Pfizer is a marketing authorization holder of Hydrocortisone sodium succinate in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of Hydrocortisone sodium succinate has submitted the same report to the regulatory authorities.  No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: 100.8 fever; body aches; Chills; This is a spontaneous report from a contactable Consumer. This 20-Year-old Female (non-pregnant) Consumer (patient) received second dose of bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number: EN6205; Expiration date was not reported) via unspecified route of administration on 03Mar2021 at 09:00 AM, as DOSE 2, SINGLE for covid 19 immunization (age at vaccination:20-Year-old). The medical history and concomitant medications were not reported. Patient previously received BNT162B2 as dose 1, single on an unspecified date for covid 19 immunization. The patient had not received any other vaccine in four weeks, the patient was not tested positive either before or after vaccination. On an unspecified date the patient experienced 100.8 fever, body aches and chills. The patient's laboratorial value included body temperature 100.8 on an unspecified date. The outcome of the events was reported as unknown.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Nausea, Pain
Clinical narrative: fever; Headache; Extreme fatigue; Body aches; I spent 48hrs vomiting; Nauseated; Diarrhea; This is a spontaneous report from a contactable consumer or other non hcp. A 41-year-old non-pregnant female patient (consumer) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Right on 05Feb2021 13:15 (age was 41-year-old and was non-pregnant at the time of vaccination) as DOSE 2, SINGLE for Covid-19 immunisation. The medical history included Occipital and Trigeminal neuralgia, and the known allergies included Penicillin, Phenergan (phenagren), codiene, and mustard, egg, sweet potato, walnuts as food allergies from an unknown date and unknown if ongoing. The patient previously took Phenergan [Promethazine] for drug hypersensitivity and Codeine for drug hypersensitivity. The historical vaccine included BNT162b2 for Covid-19 Immunisation on 15Jan2021 at 2.00 PM. The concomitant medication included gabapentin (GABAPENTIN) taken for an unspecified indication as other medications in two weeks, start and stop date were not reported. The patient stated that the first dose caused a horrible headache (or neuralgia attack) the day after and lasted about 24hrs. The day after the second dose on 06Feb2021 at 02:00, the patient developed a fever, headache, extreme fatigue and body-aches. Thereafter, the patient mentioned she spent 48hrs suffering from symptoms including vomiting, nauseated and with diarrhoea which started on 06Feb2021. Those symptoms lasted about 48hrs. The patient had to get tested before returning to work at the Covid call center. The patient underwent lab tests and procedures which included sars-cov-2 test (Covid test post vaccination) which was found to be negative on 12Feb2021. Covid test type post vaccination was done by Nasal Swab and Covid test name post vaccination was by PCR. There was no treatment received for the events. Patient did not have Covid prior vaccination. The outcome of events was reported as recovered for all the events in Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Vomiting
Clinical narrative: fever; Headache; Extreme fatigue; Body aches; I spent 48hrs vomiting; Nauseated; Diarrhea; This is a spontaneous report from a contactable consumer or other non hcp. A 41-year-old non-pregnant female patient (consumer) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Right on 05Feb2021 13:15 (age was 41-year-old and was non-pregnant at the time of vaccination) as DOSE 2, SINGLE for Covid-19 immunisation. The medical history included Occipital and Trigeminal neuralgia, and the known allergies included Penicillin, Phenergan (phenagren), codiene, and mustard, egg, sweet potato, walnuts as food allergies from an unknown date and unknown if ongoing. The patient previously took Phenergan [Promethazine] for drug hypersensitivity and Codeine for drug hypersensitivity. The historical vaccine included BNT162b2 for Covid-19 Immunisation on 15Jan2021 at 2.00 PM. The concomitant medication included gabapentin (GABAPENTIN) taken for an unspecified indication as other medications in two weeks, start and stop date were not reported. The patient stated that the first dose caused a horrible headache (or neuralgia attack) the day after and lasted about 24hrs. The day after the second dose on 06Feb2021 at 02:00, the patient developed a fever, headache, extreme fatigue and body-aches. Thereafter, the patient mentioned she spent 48hrs suffering from symptoms including vomiting, nauseated and with diarrhoea which started on 06Feb2021. Those symptoms lasted about 48hrs. The patient had to get tested before returning to work at the Covid call center. The patient underwent lab tests and procedures which included sars-cov-2 test (Covid test post vaccination) which was found to be negative on 12Feb2021. Covid test type post vaccination was done by Nasal Swab and Covid test name post vaccination was by PCR. There was no treatment received for the events. Patient did not have Covid prior vaccination. The outcome of events was reported as recovered for all the events in Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: Fever; body aches; arm very sore; This is a spontaneous report from a contactable consumer. This 59-year-old Male consumer reported that.  A 59-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: En6203), dose 1 via an unspecified route of administration, administered in Arm Left on 04Mar2021 15:30 as (At the age of 59-years) dose 1, single for covid-19 immunisation. No other medical history was reported, and Patient received other medications (Not specified) in two weeks. It was Unknown if covid prior vaccination. No covid tested post vaccination. No known allergies ware reported. No other vaccine in four weeks. The patient experienced fever, body aches, arm very sore on 04Mar2021 05:00. Patient did not receive any other treatment for events.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Flushing, Heart rate, Heart rate increased
Clinical narrative: My heart rate was elevated; Face was brightly flushed; Anxiety for about 24 hours.; This is a spontaneous report from a contactable consumer or other non-health care professional (patient).  A 68-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration, administered in right arm on 19Feb2021 01:00 AM (at the age of 68-years-old) as dose 1, single for COVID-19 immunization. Medical history included infant immunization from an unknown date and unknown if ongoing known allergies infant immunization (over 60 years ago and unclear which one). Concomitant medication included multivitamin. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. Facility type vaccine School or Student Health Clinic. After approx 30 minutes of receiving vaccine, my heart rate was elevated and patient face was brightly flushed lasting for several hours. This resulted in overall anxiety for about 24 hours on 19Feb2021 at 14:00. For this reason, she concerned about taking the second dose scheduled at a drive event March 12. No treatment was received for the events. The patient underwent lab tests and procedures which included heart rate: elevated on unknown date. The outcome of the events was reported as recovered on unknown date in 2021.  No follow-up attempts are possible, information about batch/ lot number cannot be obtained.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature abnormal, Hypoaesthesia, Hypoaesthesia oral, Peripheral coldness
Clinical narrative: Body temperature was still 96.7; 2 hours after injection had numb lips and jaw; 2 hours after injection had numb lips and jaw; Very cold arms, hands, and feet; This is a spontaneous report from a contactable consumer (the patient).A 68-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6200), via an unspecified route of administration, administered in Arm Left on 02Mar2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunization. Medical history included allergies to Apples, citrus, garlic, mushrooms, tea, white potatoes. Concomitant medication included pseudoephedrine hydrochloride (SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]). The patient did not receive any other vaccine in four weeks prior to vaccination. Prior to vaccination, the patient was not diagnosed with COVID. The patient has not been tested for COVID post vaccination. On 02Mar2021 at 12:00, (2 hours after injection) the patient had numb lips and jaw, very cold arms, hands, and feet and on 03Mar2021, the patient's body temperature was still 96.7. It was reported that two hours after injection had numb lips and jaw. Very cold arms, hands, and feet. 24 hours later body temperature was still 96.7. This persisted for 36 hours from the time of the shot. The adverse events did not result in emergency room visit or Physician office visit. On 03Mar2021, the patient underwent lab tests which included body temperature was still 96.7 (24 hours later). The patient did not receive any treatment for events. The patient recovered from events on unspecified date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Intermittent fever; Aches; Chills; Fatigue; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 23-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9266, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 13Feb2021 at 10:30 am (age at vaccination was 23 years) at a dose 1, single for COVID-19 immunization. The patient's medical history included Postural Orthostatic Tachycardia Syndrome, not formally diagnosed from an unknown date. Concomitant medications the patient received within 2 weeks of vaccination included testosterone cipionate (TESTOSTERONE CYPIONATE) and venlafaxine HCL both taken for an unspecified indication. The facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 14Feb2021, the patient experienced intermittent fever, aches, and chills for 5-6 days after receiving the vaccine in addition constant fatigue for up to 7 days after receiving the vaccine. The side effects were severe enough to negatively impact the entire following work week. No treatment was received for the adverse events. The outcome of the events was resolved on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: body aches; fever; Chills; This is a spontaneous report from a contactable consumer (patient). This 45-year-old female patient first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: EL9264) via an unspecified route of administration in left upper arm on 02Mar2021 10:15 (age at vaccination was 45 years) as DOSE 1, SINGLE for COVID-19 immunisation at Hospital. The patient's medical history included she got sick with the flu shot. She did not know the exact date that she got the flu shot it was over 15 years ago. The patient's concomitant medications were not reported. She did not receive other vaccines prior vaccinations within 4 weeks. Her history of all previous immunization with the Pfizer vaccine considered as suspect were none. Additional vaccines administered on same date of the Pfizer suspect were none. The patient experienced body aches and fever on 02Mar2021 20:00 and chills on unknown date. She was asking if those were normal, how long should they last, and when should she go to the doctor. She was getting scared because she was never sick. The patient did not visit emergency room and got an appointment. The outcome of events body aches and fever was not recovered and outcome of event chills was unknown.  No follow-up attempts were possible. No Further Information was expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Renal pain, Vaccination site pain
Clinical narrative: Low grade fever; Night following injection and kidney pain the following day; Night following injection and kidney pain the following day; This is a spontaneous report from a contactable consumer (patient).  A 28-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration, administered in right arm on 03Mar2021 14:15 (at the age of 28-years-old) as dose 1, single for covid-19 immunization. The patient medical history included allergy to sulfa drugs. Concomitant medication included vitamin d [vitamin d nos] (VITAMIN D) taken for an unspecified indication, from an unknown date. Other medications the patient received within 2 weeks of vaccination included Vitamin D pill. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that, on 04Mar2021 the patient experienced Low grade fever night following injection and kidney pain the following day. He lacerated his kidney several years ago and a day following the first dose both of his kidneys are in pain. Patient received the vaccine on 03Mar21, woke up with a fever around 1 am 04Mar2021, and had sharp kidney pain from approximately 6:30 am to 7 pm 04Mar2021. Patient did not receive any treatment for the adverse event. The outcome of the events was not recovered.  No follow-up attempts are needed. information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pruritus, Pyrexia
Clinical narrative: low gade fever for 2.days; itching on my eyelids; pain in lower back joint; This is a spontaneous report from contactable consumer (patient herself). A 56-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL9263, expiry date: unknown) via unspecified route of administration, in right arm on 31Jan2021 09:00 (age at vaccination: 56-years) as dose 1, single for covid-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included high. bp, high cholesterol, high thyroid and mild depression from an unspecified date and unknown if ongoing. Past drug included known allergies from phenobarbital. Concomitant medications included Levothyroxine, cymbalta, gabapentin, valsartan, statin taken in two weeks, taken for unspecified indication, start and stop date not given. On an unspecified date, patient experienced low grade fever for 2.days, itching on my eyelids and pain in lower back joint. Treatment was given for the adverse events with Tylenol, Benadryl. The patient did not get covid before vaccination and was not tested for covid post vaccination. The outcome of the events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Hyperhidrosis, Pyrexia, Weight
Clinical narrative: fever; sweating.; This is a spontaneous report from a contactable consumer. A 64-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 28Feb2021 17:30 (age at vaccination: 64 years) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included overweight, was a smoker, diabetic, blood pressure, thyroid disorder and several back surgeries. Patient is fused front, back, and sideways. The patient takes blood pressure and thyroid medicine. On 04Mar2021, 3 days after, the patient experienced fever, sweating. On an unknown date, the patient's body temperature was 99.5. The events did not require physician's office or emergency room visit. The patient had no prior vaccinations within 4 weeks: but had flu shot months ago. The outcome of the events was unknown. There was no product quality complaint (PQC) present.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Heart rate increased, Lethargy, Pain
Clinical narrative: Rapid heart rate immediately after; light headed for 4 days; aches for 48 hours; lethargic for 3 days; loss of appetite for 3 days; This is a spontaneous report from a contactable other hcp (patient). A 67-years-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 24Feb2021 11:30 (Lot Number: EN6200) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. on 24Feb2021 11:30 patient experienced rapid heart rate immediately after, light headed for 4 days, aches for 48 hours, lethargic for 3 days, loss of appetite for 3 days. prior vaccination and post vaccination patient did not tested for covid. Patient did not received treatment. Outcome of the events was recovering.  No follow up attempts are possible. No further information is expected.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: temperature/ temperature elevation; stuffy nose; scratchy throat; he was having trouble with lightheadedness, but not dizziness,they put a heart monitor on him for 4 weeks and found absolutely nothing, but that is gone now, he doesn't feel that anymore.; he was coughing stuff like a cold or flu; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient) via medical information team.  A 73-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot Number: EN6199), via an unspecified route of administration on 03Mar2021 at about 1:00 PM ESP (age at the time of vaccination was 73 years) as dose 1, single in left arm for covid-19 immunisation. The patient medical history included Covid-19 in Aug2020, lightheadedness. It was reported that the patient started a thyroid medication about a month and a half ago, no further details provide about this medication. On 03Mar2021, the patient experienced temperature and on 04Mar2021, the patient experienced temperature elevation. On an unspecified date in Mar2021, the patient experienced stuffy nose, scratchy throat and he was coughing stuff like a cold or flu. It was stated that the patient, 73 years old, got his first dose of Pfizer's COVID-19 vaccine yesterday. He had a bit of temperature today, earlier it was 100.2F, then 101F, then 100.6F. It was enquired if it was normal to have a temp like that with the vaccine. He wanted to know if he could take Tylenol or ibuprofen. He also has a stuffy nose and not exactly a cough but a scratchy throat, he was coughing stuff like a cold or flu, he was wondering if he should get tested for COVID. He had COVID back in the end of August. He was wondering if he would test positive from the vaccine. It was reported that the patient calling about the Pfizer COVID-19 vaccine who received their first dose yesterday afternoon in their local area and today about the same time they took their temperature and it was 100.2-100.3 degrees Fahrenheit maybe an hour ago. He said he took his temperature a half hour ago and it was 101 degrees Fahrenheit, then he checked it again later and it was down to 100.5 degrees Fahrenheit. He said he would like to know if it is normal to have a temperature a whole day later. He said he got his first dose injection 03Mar at about 01:00PM ESP. The patient said his Pfizer COVID-19 vaccine card was a handwritten card, on the back it says his next dose will take place 24Mar2021 at the same time. Reportedly the patient said he was having trouble with lightheadedness, but not dizziness, they put a heart monitor on him for 4 weeks and found absolutely nothing, but that was gone now, he doesn't feel that anymore. The patient underwent lab tests and procedures which included body temperature: 100.2 fahrenheit, body temperature: 101 Fahrenheit and body temperature: 100.6 fahrenheit all on 04Mar2021. Information about the AE treatment was not provided. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Decreased appetite, Lethargy, Pyrexia, Sinusitis
Clinical narrative: Fever; inflamed sinuses; lethargy; lack of appetite; mental confusion; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 52-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: en6201), via an unspecified route of administration, administered in Left arm on 18Feb2021 03:30 pm (52-year-old at the time of vaccination) as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. The concomitant medications were reported as none. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: el8982), via an unspecified route of administration, administered in Left arm on 28Jan2021 03:30 pm (52-year-old at the time of vaccination) as dose 1, single for covid-19 immunisation. The patient had not received any vaccine within four weeks. The patient does not have COVID prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 19Feb2021 12:30 pm, 21 hrs after vaccination, the patient experienced Fever, inflamed sinuses, lethargy, lack of appetite, mental confusion. No treatment was received for the events. The outcome of the events were recovered with Sequel.  No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Hypoaesthesia, Pain
Clinical narrative: Numbness; pain; difficulty walking; This is a spontaneous report from a contactable consumer or other non-Health Care Professional (patient). A 74-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6202 and Expiry date: Unknown) via an unspecified route of administration, administered in Arm Left on 27Feb2021 12:00 as DOSE 1, SINGLE for covid-19 immunization. Medical history included myasthenia gravis, small fibre neuropathy, Sjogren's syndrome, orthostatic hypertension. The patient previously took cipro [ciprofloxacin hydrochloride] and experienced drug hypersensitivity. Concomitant medication(s) included hydroxychloroquine sulfate (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), pyridostigmine bromide (MESTINON), droxidopa (NORTHERA), Vitamin D Nos taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient was not diagnosed with Covid 19 and has not been tested for Covid-19 Since the vaccination. On 27Feb2021 12:15 the patient experienced numbness, pain, and difficulty walking shortly after vaccine. Reported to attendant. Was told to contact Primary care if didn't improve. I have not done so. The symptoms continued to increase for 3 days and then began subsiding. Walking has returned to normal, but still some residual pain and numbness. The patient did not have covid prior vaccination and was not tested post vaccination. The patient did not receive any treatment for the events. The outcome of events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pyrexia, Vaccination site pain
Clinical narrative: Fever; no power; Pain at injection site; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 36-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 03Mar2021 14:45 (at the age of 36 years old) (Batch/Lot Number: EN6206) as single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome. The patient has no known allergies. There were no concomitant medications. Previously the patient took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (at the age of 36 years old) as single dose for COVID-19 immunisation. On 03Mar2021 20:00, the patient experienced Fever, no power, Pain at injection site. No other vaccines were received in four weeks. No treatment was received for the adverse events. The patient was not diagnosed with COVID-19 prior to the vaccination and has not been tested for COVID-19 since the vaccination. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate, Heart rate increased
Clinical narrative: Feels like I have a rapid heart rate; shortness of breath; This is a spontaneous report from a non-contactable consumer (patient). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection Lot Number: EN6205) via unspecified route of administration on 01Mar2021 13:15 (37-year-old at the time of vaccination) as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. No covid prior vaccination and not tested covid post vaccination. The patient had no known allergies. On 03Mar2021, the patient felt like having a rapid heart rate, shortness of breath. Treatment was not received. The patient underwent lab tests and procedures which included heart rate resulted as rapid on an 03Mar2021. The outcome of the events was not resolved.  No follow up attempts are possible. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia, Renal pain, Vaccination site pain
Clinical narrative: Fever of 104 F; kidney pain; body aches; soreness in the injection site for more than 2 days; This is a spontaneous report from a Non contactable male consumer reported that. A 47-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 24Feb2021 (Batch/Lot Number: EL6198) as DOSE 2 SINGLE for covid-19 immunization (Age at vaccination 47 years). The patient medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. There were no allergies reported. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. On 25Feb2021, The patient experienced fever of 104 f, kidney pain, body aches and soreness in the injection site for more than 2 days. The patient underwent lab tests and procedures which included body temperature: 104 Fahrenheit on an unspecified date. The patient received treatment with Aspirin and Tylenol. The event outcome was Recovering.  No follow up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia, Vaccination site erythema
Clinical narrative: Fever of 101.8 for 18 hours; Chills and body aches for 2 days; Chills and body aches for 2 days; Red around injection site starting at about 5 across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3 across now.; Red around injection site starting at about 5 across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3 across now; Red around injection site starting at about 5 across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3 across now; Red around injection site starting at about 5 across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3 across now; This is a spontaneous report from a contactable consumer reported for herself. A 68-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809), dose 1 via an unspecified route of administration, administered in Arm Right on 24Feb2021 13:45 (at the age of 68-years-old) as a single dose for covid-19 immunization. Medical history included sinusitis, immunodeficiency common variable, covid-19. The patient previously took aspirin [acetylsalicylic acid] and ibuprofen and experienced drug hypersensitivity. The patient received pneumococcal vaccine for immunisation on left arm on 09Feb2021 within four weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Feb2021 23:30, the patient experienced fever of 101.8 for 18 hours. Chills and body aches for 2 days. Red around injection site starting at about 5" across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3" across now. The patient did not receive any treatment. Outcome of the event fever was recovered on 25Feb2021 17:30; chills and body aches was recovered on 27Feb2021; while rest other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Fever of 101.8 for 18 hours; Chills and body aches for 2 days; Chills and body aches for 2 days; Red around injection site starting at about 5 across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3 across now.; Red around injection site starting at about 5 across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3 across now; Red around injection site starting at about 5 across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3 across now; Red around injection site starting at about 5 across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3 across now; This is a spontaneous report from a contactable consumer reported for herself. A 68-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809), dose 1 via an unspecified route of administration, administered in Arm Right on 24Feb2021 13:45 (at the age of 68-years-old) as a single dose for covid-19 immunization. Medical history included sinusitis, immunodeficiency common variable, covid-19. The patient previously took aspirin [acetylsalicylic acid] and ibuprofen and experienced drug hypersensitivity. The patient received pneumococcal vaccine for immunisation on left arm on 09Feb2021 within four weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Feb2021 23:30, the patient experienced fever of 101.8 for 18 hours. Chills and body aches for 2 days. Red around injection site starting at about 5" across. The area is slightly raised and hot to touch. Sore and itches. It is 5 days later and about 3" across now. The patient did not receive any treatment. Outcome of the event fever was recovered on 25Feb2021 17:30; chills and body aches was recovered on 27Feb2021; while rest other events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Hyperhidrosis, Pyrexia
Clinical narrative: 103 fever starting 8 hours after shot and last 36 hours, continued 99 fever.; Terrible exhaustion; lack of appetite; uncontrollable sweating; This is a spontaneous report from a contactable consumer. A 40-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: Unknown), via an unspecified route of administration, administered in Arm Left on 27Feb2021 09:15 as DOSE 2, SINGLE (at the age of 40-years-old) for covid-19 immunisation. The patient's medical history included hypothyroidism. The patient's concomitant medications included levothyroxine sodium (SYNTHROID); ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Feb2021 at 17:00, the patient experienced 103 fever starting 8 hours after shot and last 36 hours, continued 99 fever, terrible exhaustion, lack of appetite and uncontrollable sweating. The patient did not received the treatment. The outcome of the event was recovering.    No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: had a fever afterthe 1st dose of the vaccine yesterday; This is a spontaneous report from a contactable consumer (patient), from Pfizer-sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, the patient had a fever after the 1st dose of the vaccine yesterday. She wants to know if she is contagious. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.